IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia
Authors:
- 16 February 2013
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 11 (5) , 881-893
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic ArthritisNew England Journal of Medicine, 2012
- Systematic Review of Tocilizumab for Rheumatoid Arthritis: A New Biologic Agent Targeting the Interleukin-6 ReceptorClinical Therapeutics, 2012
- The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid ArthritisArthritis, 2011
- Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI studyModern Rheumatology, 2010
- Impact of polymorphisms of the major histocompatibility complex class II, interleukin‐10, tumor necrosis factor‐α and cytotoxic T‐lymphocyte antigen‐4 genes on inhibitor development in severe hemophilia AJournal of Thrombosis and Haemostasis, 2009
- Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension studyAnnals of the Rheumatic Diseases, 2009
- Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IXBlood, 2008
- Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A miceJournal of Thrombosis and Haemostasis, 2008
- Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe HemophiliaNew England Journal of Medicine, 2007
- Haemophilia prophylaxis in young patients–a long‐term follow‐upJournal of Internal Medicine, 1997